Sketris IS - Search Results

1

Godin JR, Sketris IS, Belitsky P. Godin JR, et al. Among authors: sketris is. Drug Intell Clin Pharm. 1986 Jun;20(6):504-5. doi: 10.1177/106002808602000617. Drug Intell Clin Pharm. 1986. PMID: 3522164 No abstract available.

2

Efficacy of a low-dose two-drug regimen of oral cyclosporine and delayed alternate day prednisone for immunosuppression in cadaver kidney transplantation.

Belitsky P, MacDonald A, Cohen A, VGivner M, Sketris I. Belitsky P, et al. Transplant Proc. 1988 Jun;20(3 Suppl 3):78-81. Transplant Proc. 1988. PMID: 3291314 No abstract available.

3

Effect of coadministration of acyclovir and cyclosporine on kidney function and cyclosporine concentrations in renal transplant patients.

Dugandzic RM, Sketris IS, Belitsky P, Schlech WF 3rd, Givner ML. Dugandzic RM, et al. Among authors: sketris is. DICP. 1991 Mar;25(3):316-7. doi: 10.1177/106002809102500321. DICP. 1991. PMID: 2028640 Clinical Trial. No abstract available.

4

Renal transplantation in secondary oxalosis.

Roberts RA, Sketris IS, MacDonald AS, Belitsky P. Roberts RA, et al. Among authors: sketris is. Transplantation. 1988 May;45(5):985-6. doi: 10.1097/00007890-198805000-00029. Transplantation. 1988. PMID: 3285545 No abstract available.

5

Effect of calcium-channel blockers on cyclosporine clearance and use in renal transplant patients.

Sketris IS, Methot ME, Nicol D, Belitsky P, Knox MG. Sketris IS, et al. Ann Pharmacother. 1994 Nov;28(11):1227-31. doi: 10.1177/106002809402801101. Ann Pharmacother. 1994. PMID: 7849332

6

Comparison of the pharmacokinetics of cyclosporine Sandimmune with Sandimmune Neoral in stable renal transplant patients.

Sketris IS, Lawen JG, Beauregard-Zollinger L, Belitsky P, Landsberg D, Givner ML, Keown P. Sketris IS, et al. Transplant Proc. 1994 Oct;26(5):2961-3. Transplant Proc. 1994. PMID: 7940935 Clinical Trial. No abstract available.

7

Approaching the therapeutic window for cyclosporine in kidney transplantation: a prospective study.

Mahalati K, Belitsky P, West K, Kiberd B, Fraser A, Sketris I, Macdonald AS, McAlister V, Lawen J. Mahalati K, et al. J Am Soc Nephrol. 2001 Apr;12(4):828-833. doi: 10.1681/ASN.V124828. J Am Soc Nephrol. 2001. PMID: 11274245

8

Neoral monitoring by simplified sparse sampling area under the concentration-time curve: its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation.

Mahalati K, Belitsky P, Sketris I, West K, Panek R. Mahalati K, et al. Transplantation. 1999 Jul 15;68(1):55-62. doi: 10.1097/00007890-199907150-00011. Transplantation. 1999. PMID: 10428267

9

Influence of drug formulation on utilization and outcomes: Neoral and monitoring by sparse sample area under the curve.

Belitsky P, Mahalati K, West K, Sketris I. Belitsky P, et al. Transplant Proc. 1999 May;31(3):1667-8. doi: 10.1016/s0041-1345(99)00089-5. Transplant Proc. 1999. PMID: 10331038 Clinical Trial. No abstract available.

10

Kidney transplantation, the Halifax experience.

Belitsky P, MacDonald AS, Lawen J, McAlister V, Bitter-Suermann H, Kiberd B, West K, Sketris I. Belitsky P, et al. Clin Transpl. 1996:231-40. Clin Transpl. 1996. PMID: 9286572

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

156 results

Search Page